Danielle Henry is an Oncology physician affiliated with Orlando Health. OpenAlex indexes 23 publications with 1,990 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1400 S Orange Ave
Orlando, FL 328062134
Telephone
407-648-3800Registry record last updated 21 Jul 2022.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AXOGENProgram year20251 payment
- Merit Medical Systems IncProgram year20251 payment
- Davol Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
34.3%Opioid Agonist13%Oxycodone Hcl100%Part D≥12 patientsGabapentinoids11.1%Gabapentin100%Part D≥12 patients+ 1 more class in this area
Respiratory
28.7%Opioid Agonist28.7%Hydrocodone-Acetaminophen100%Part D≥29 patientsAnti-infectives
25%Tetracycline-class Drug25%Doxycycline Hyclate100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Residual Nodal Disease after Positive Sentinel Lymph Node Biopsy in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Implication for Completion Dissection
International Journal of Radiation Oncology*Biology*Physics
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Eleftherios Mamounas, MD
Orlando Health
Manoel Dos Passos Galvao Neto, MD
Orlando Health
Karoly Horvath, MD
Orlando Health
Mohamed Elshazly, MD
Orlando Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”